Product Code: RP-ID-10265644 |
Published Date: 21 Oct 2022 |
Region: NA |
Category: Healthcare & Pharmaceuticals |
Report ID: 10265644
Market Overview:
Global Pyrogen Testing Market Size study, by Application (Pharmaceuticals and Biologicals Manufacturing, Medicals Devices Manufacturing, Other Applications) By Product (Kits and Reagents, Services, Instruments) By TEST (LAL Test, In Vitro Pyrogen Test, Rabbit Test) and Regional Forecasts 2019-2026
Global Pyrogen Testing Market is valued approximately USD 758.4 million in 2018 and is anticipated to grow with a healthy growth rate of more than 11.50% over the forecast period 2019-2026. Pyrogen testing is a procedure that defines the existence of bacterial toxins in biotechnological products, vaccines and drugs, that induces illness in humans. This pyrogen testing also determines the existence of microorganisms and their metabolites in drugs throughout the manufacturing process. Pyrogen testing is carried out during manufacturing process of drugs and vaccine to avert infection and also to ensure the non-appearance of toxic molecular products. Rapid increase in pharmaceutical and biotechnology industries coupled with
increasing number of new drug launches are key driving forces of market growth. Further, strong r&d investments in the life sciences industry and high incidence and large economic burden of chronic diseases also contribute towards market growth. According to World Health Organization, prevalence of chronic diseases is expected to rise by 57% by the year 2020. Moreover, increasing pharmaceutical outsourcing is expected to create significant growth opportunity in the market over the forecast period. However, high degree of consolidation impedes the growth of the market over the forecast period of 2019-2026.
The regional analysis of global Pyrogen Testing market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America and Rest of the World. North America is the leading/significant region across the world in terms of market share owing to the growing government support, presence of large biotechnological firms coupled with the well-established healthcare infrastructure. Whereas, Asia-Pacific is also anticipated to exhibit highest growth rate / CAGR over the forecast period 2019-2026. Factors such as low stringency in government regulations in drug development and improving healthcare expenditure would create lucrative growth prospects for the Pyrogen Testing market across Asia-Pacific region.
Major market player included in this report are:
Associates of Cape Cod, Inc.
Charles River Laboratories, Inc.
Lonza Group
Merck Kgaa
Ellab A/S
Genscript
Hyglos GmbH
Thermo Fisher Scientific, Inc.
Wako Chemicals Usa, Inc.
WUXI Pharmatech (Cayman) Inc.
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Application:
Pharmaceuticals and Biologicals Manufacturing
Medicals Devices Manufacturing
Other Applications
By Product:
Kits and Reagents
Services
Instruments
By TEST:
LAL Test
In Vitro Pyrogen Test
Rabbit Test
By Region:
North America
U.S.
Canada
Europe
UK
Germany
Asia Pacific
China
India
Japan
Latin America
Brazil
Mexico
Rest of the World
Furthermore, years considered for the study are as follows:
Historical year – 2016, 2017
Base year – 2018
Forecast period – 2019 to 2026
Target Audience of the Global Pyrogen Testing Market in Market Study:
Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors
Charles River Laboratories, Inc.
Lonza Group
Merck Kgaa
Ellab A/S
Genscript
Hyglos GmbH
Thermo Fisher Scientific, Inc.
Wako Chemicals Usa, Inc.
WUXI Pharmatech (Cayman) Inc.
Related Reports
Proof of Quality & Reliability
